Young head and neck cancer patients are at increased risk of developing oral mucositis and trismus

Objectives To evaluate cancer treatment–related toxicities in young head and neck cancer (HNC) patients. Material and methods A total of 44 patients were included in the present retrospective cohort study, which was designed to access oral toxicities of cancer treatment in young ( 58 years of age, G...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Supportive care in cancer 2020-09, Vol.28 (9), p.4345-4352
Hauptverfasser: Morais-Faria, Karina, Palmier, Natalia Rangel, de Lima Correia, Jaqueline, de Castro Júnior, Gilberto, Dias, Reinaldo Brito, da Graça Pinto, Henrique, Lopes, Marcio Ajudarte, Ribeiro, Ana Carolina Prado, Brandão, Thaís Bianca, Santos-Silva, Alan Roger
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4352
container_issue 9
container_start_page 4345
container_title Supportive care in cancer
container_volume 28
creator Morais-Faria, Karina
Palmier, Natalia Rangel
de Lima Correia, Jaqueline
de Castro Júnior, Gilberto
Dias, Reinaldo Brito
da Graça Pinto, Henrique
Lopes, Marcio Ajudarte
Ribeiro, Ana Carolina Prado
Brandão, Thaís Bianca
Santos-Silva, Alan Roger
description Objectives To evaluate cancer treatment–related toxicities in young head and neck cancer (HNC) patients. Material and methods A total of 44 patients were included in the present retrospective cohort study, which was designed to access oral toxicities of cancer treatment in young ( 58 years of age, Group II, n  = 22) HNC patients with similar tumor stage and treatment protocols. Oral mucositis (OM), xerostomia, dysphagia, dysgeusia, trismus, and radiodermatitis were assessed during days 7th, 21st, and 35th of head and neck radiotherapy (HNRT) according to previously validated scales (World Health Organization criteria and the National Cancer Institute and Common Terminology Criteria for Adverse Events version 4.0). Results Patients from both groups showed high incidence and severity of oral toxicities by the end of the HNRT with OM (81.9% (Group I); 63.6% (Group II)) and xerostomia (72.6% (Group I); 77.2% (Group II)) being the most prevalent toxicities. No differences regarding xerostomia, dysphagia, dysgeusia, and radiodermatitis incidences or severity could be observed between groups. However, higher incidences and severity of OM at 21st and 35th fractions (odds ratio = 2.22 and 5.71, respectively) and trismus at 21st and 35th fractions (odds ratio = 6.17 and 14.5, respectively) were observed throughout the treatment in young patients when compared to older patients ( p  
doi_str_mv 10.1007/s00520-019-05241-x
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_gale_infotracmisc_A630447329</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A630447329</galeid><sourcerecordid>A630447329</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-b5e3c88c2ed553f0e815f1d7985693cd47df555cea3ba1b132df7b299bdb8b13</originalsourceid><addsrcrecordid>eNqNkU1rFTEUhoMo9lr9Ay4k4EaQqfmcmSzLxS8ouOnGVcgkZ65pZ5JrMqP133vaW1sUESeLScLzvhzyEPKcsxPOWPemMqYFaxg3DW4Ub64ekA1XUjadlOYh2TCDl0pqfUSe1HrBGO86LR6TI8kNF1KbDRk-5zXt6BdwgboUaAJ_Sb1LHgrduyVCWip1BahbaEy-gKsQaIn1kuaRBvgGU95HbMjFTXRefa5xifWma0FsXutT8mh0U4Vnt_9jcv7u7fn2Q3P26f3H7elZ45USSzNokL7vvYCgtRwZ9FyPPHSm162RPqgujFprD04Ojg9cijB2gzBmCEOPx2Py6lC7L_nrCnWxc6wepsklyGu1QkrVGvxaRF_-gV7ktSQczgolWtmaVvX31M5NYGMa81Kcvy61p61kSnVSGKRO_kLhCjBHnxOMEe9_C4hDwJdca4HR7kucXflhObPXXu3Bq0Wv9sarvcLQi9uJ12GGcBf5JRKB_gB8hyGP1aM4D3cYw0bNtegM7lS7jQuqzWmL7heMvv7_KNLyQFck0g7K_dv9Y_6fVdfNww</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2426369648</pqid></control><display><type>article</type><title>Young head and neck cancer patients are at increased risk of developing oral mucositis and trismus</title><source>SpringerNature Journals</source><source>Web of Science - Science Citation Index Expanded - 2020&lt;img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /&gt;</source><creator>Morais-Faria, Karina ; Palmier, Natalia Rangel ; de Lima Correia, Jaqueline ; de Castro Júnior, Gilberto ; Dias, Reinaldo Brito ; da Graça Pinto, Henrique ; Lopes, Marcio Ajudarte ; Ribeiro, Ana Carolina Prado ; Brandão, Thaís Bianca ; Santos-Silva, Alan Roger</creator><creatorcontrib>Morais-Faria, Karina ; Palmier, Natalia Rangel ; de Lima Correia, Jaqueline ; de Castro Júnior, Gilberto ; Dias, Reinaldo Brito ; da Graça Pinto, Henrique ; Lopes, Marcio Ajudarte ; Ribeiro, Ana Carolina Prado ; Brandão, Thaís Bianca ; Santos-Silva, Alan Roger</creatorcontrib><description>Objectives To evaluate cancer treatment–related toxicities in young head and neck cancer (HNC) patients. Material and methods A total of 44 patients were included in the present retrospective cohort study, which was designed to access oral toxicities of cancer treatment in young (&lt; 45 years of age, Group I, n  = 22) and old (&gt; 58 years of age, Group II, n  = 22) HNC patients with similar tumor stage and treatment protocols. Oral mucositis (OM), xerostomia, dysphagia, dysgeusia, trismus, and radiodermatitis were assessed during days 7th, 21st, and 35th of head and neck radiotherapy (HNRT) according to previously validated scales (World Health Organization criteria and the National Cancer Institute and Common Terminology Criteria for Adverse Events version 4.0). Results Patients from both groups showed high incidence and severity of oral toxicities by the end of the HNRT with OM (81.9% (Group I); 63.6% (Group II)) and xerostomia (72.6% (Group I); 77.2% (Group II)) being the most prevalent toxicities. No differences regarding xerostomia, dysphagia, dysgeusia, and radiodermatitis incidences or severity could be observed between groups. However, higher incidences and severity of OM at 21st and 35th fractions (odds ratio = 2.22 and 5.71, respectively) and trismus at 21st and 35th fractions (odds ratio = 6.17 and 14.5, respectively) were observed throughout the treatment in young patients when compared to older patients ( p  &lt; 0.01 and p  &lt; 0.05, respectively). Conclusion Young HNC patients are more affected by cancer treatment–related OM and trismus despite the similarities in clinical staging and treatment protocols with elderly patients.</description><identifier>ISSN: 0941-4355</identifier><identifier>EISSN: 1433-7339</identifier><identifier>DOI: 10.1007/s00520-019-05241-x</identifier><identifier>PMID: 31912359</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Cancer ; Cancer patients ; Cancer therapies ; Deglutition disorders ; Dysphagia ; Head &amp; neck cancer ; Head and neck cancer ; Health Care Sciences &amp; Services ; Life Sciences &amp; Biomedicine ; Medical colleges ; Medicine ; Medicine &amp; Public Health ; Mucositis ; Nursing ; Nursing Research ; Oncology ; Oncology, Experimental ; Original Article ; Pain Medicine ; Palliative care ; Radiation therapy ; Rehabilitation ; Rehabilitation Medicine ; Science &amp; Technology ; Stomatitis ; Taste disorders ; World health</subject><ispartof>Supportive care in cancer, 2020-09, Vol.28 (9), p.4345-4352</ispartof><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2020</rights><rights>COPYRIGHT 2020 Springer</rights><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>8</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000551527900046</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c442t-b5e3c88c2ed553f0e815f1d7985693cd47df555cea3ba1b132df7b299bdb8b13</citedby><cites>FETCH-LOGICAL-c442t-b5e3c88c2ed553f0e815f1d7985693cd47df555cea3ba1b132df7b299bdb8b13</cites><orcidid>0000-0003-2040-6617</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00520-019-05241-x$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00520-019-05241-x$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>315,782,786,27931,27932,28255,41495,42564,51326</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31912359$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Morais-Faria, Karina</creatorcontrib><creatorcontrib>Palmier, Natalia Rangel</creatorcontrib><creatorcontrib>de Lima Correia, Jaqueline</creatorcontrib><creatorcontrib>de Castro Júnior, Gilberto</creatorcontrib><creatorcontrib>Dias, Reinaldo Brito</creatorcontrib><creatorcontrib>da Graça Pinto, Henrique</creatorcontrib><creatorcontrib>Lopes, Marcio Ajudarte</creatorcontrib><creatorcontrib>Ribeiro, Ana Carolina Prado</creatorcontrib><creatorcontrib>Brandão, Thaís Bianca</creatorcontrib><creatorcontrib>Santos-Silva, Alan Roger</creatorcontrib><title>Young head and neck cancer patients are at increased risk of developing oral mucositis and trismus</title><title>Supportive care in cancer</title><addtitle>Support Care Cancer</addtitle><addtitle>SUPPORT CARE CANCER</addtitle><addtitle>Support Care Cancer</addtitle><description>Objectives To evaluate cancer treatment–related toxicities in young head and neck cancer (HNC) patients. Material and methods A total of 44 patients were included in the present retrospective cohort study, which was designed to access oral toxicities of cancer treatment in young (&lt; 45 years of age, Group I, n  = 22) and old (&gt; 58 years of age, Group II, n  = 22) HNC patients with similar tumor stage and treatment protocols. Oral mucositis (OM), xerostomia, dysphagia, dysgeusia, trismus, and radiodermatitis were assessed during days 7th, 21st, and 35th of head and neck radiotherapy (HNRT) according to previously validated scales (World Health Organization criteria and the National Cancer Institute and Common Terminology Criteria for Adverse Events version 4.0). Results Patients from both groups showed high incidence and severity of oral toxicities by the end of the HNRT with OM (81.9% (Group I); 63.6% (Group II)) and xerostomia (72.6% (Group I); 77.2% (Group II)) being the most prevalent toxicities. No differences regarding xerostomia, dysphagia, dysgeusia, and radiodermatitis incidences or severity could be observed between groups. However, higher incidences and severity of OM at 21st and 35th fractions (odds ratio = 2.22 and 5.71, respectively) and trismus at 21st and 35th fractions (odds ratio = 6.17 and 14.5, respectively) were observed throughout the treatment in young patients when compared to older patients ( p  &lt; 0.01 and p  &lt; 0.05, respectively). Conclusion Young HNC patients are more affected by cancer treatment–related OM and trismus despite the similarities in clinical staging and treatment protocols with elderly patients.</description><subject>Cancer</subject><subject>Cancer patients</subject><subject>Cancer therapies</subject><subject>Deglutition disorders</subject><subject>Dysphagia</subject><subject>Head &amp; neck cancer</subject><subject>Head and neck cancer</subject><subject>Health Care Sciences &amp; Services</subject><subject>Life Sciences &amp; Biomedicine</subject><subject>Medical colleges</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Mucositis</subject><subject>Nursing</subject><subject>Nursing Research</subject><subject>Oncology</subject><subject>Oncology, Experimental</subject><subject>Original Article</subject><subject>Pain Medicine</subject><subject>Palliative care</subject><subject>Radiation therapy</subject><subject>Rehabilitation</subject><subject>Rehabilitation Medicine</subject><subject>Science &amp; Technology</subject><subject>Stomatitis</subject><subject>Taste disorders</subject><subject>World health</subject><issn>0941-4355</issn><issn>1433-7339</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>AOWDO</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNkU1rFTEUhoMo9lr9Ay4k4EaQqfmcmSzLxS8ouOnGVcgkZ65pZ5JrMqP133vaW1sUESeLScLzvhzyEPKcsxPOWPemMqYFaxg3DW4Ub64ekA1XUjadlOYh2TCDl0pqfUSe1HrBGO86LR6TI8kNF1KbDRk-5zXt6BdwgboUaAJ_Sb1LHgrduyVCWip1BahbaEy-gKsQaIn1kuaRBvgGU95HbMjFTXRefa5xifWma0FsXutT8mh0U4Vnt_9jcv7u7fn2Q3P26f3H7elZ45USSzNokL7vvYCgtRwZ9FyPPHSm162RPqgujFprD04Ojg9cijB2gzBmCEOPx2Py6lC7L_nrCnWxc6wepsklyGu1QkrVGvxaRF_-gV7ktSQczgolWtmaVvX31M5NYGMa81Kcvy61p61kSnVSGKRO_kLhCjBHnxOMEe9_C4hDwJdca4HR7kucXflhObPXXu3Bq0Wv9sarvcLQi9uJ12GGcBf5JRKB_gB8hyGP1aM4D3cYw0bNtegM7lS7jQuqzWmL7heMvv7_KNLyQFck0g7K_dv9Y_6fVdfNww</recordid><startdate>20200901</startdate><enddate>20200901</enddate><creator>Morais-Faria, Karina</creator><creator>Palmier, Natalia Rangel</creator><creator>de Lima Correia, Jaqueline</creator><creator>de Castro Júnior, Gilberto</creator><creator>Dias, Reinaldo Brito</creator><creator>da Graça Pinto, Henrique</creator><creator>Lopes, Marcio Ajudarte</creator><creator>Ribeiro, Ana Carolina Prado</creator><creator>Brandão, Thaís Bianca</creator><creator>Santos-Silva, Alan Roger</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature</general><general>Springer</general><general>Springer Nature B.V</general><scope>AOWDO</scope><scope>BLEPL</scope><scope>DTL</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88J</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HEHIP</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2R</scope><scope>M2S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-2040-6617</orcidid></search><sort><creationdate>20200901</creationdate><title>Young head and neck cancer patients are at increased risk of developing oral mucositis and trismus</title><author>Morais-Faria, Karina ; Palmier, Natalia Rangel ; de Lima Correia, Jaqueline ; de Castro Júnior, Gilberto ; Dias, Reinaldo Brito ; da Graça Pinto, Henrique ; Lopes, Marcio Ajudarte ; Ribeiro, Ana Carolina Prado ; Brandão, Thaís Bianca ; Santos-Silva, Alan Roger</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-b5e3c88c2ed553f0e815f1d7985693cd47df555cea3ba1b132df7b299bdb8b13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Cancer</topic><topic>Cancer patients</topic><topic>Cancer therapies</topic><topic>Deglutition disorders</topic><topic>Dysphagia</topic><topic>Head &amp; neck cancer</topic><topic>Head and neck cancer</topic><topic>Health Care Sciences &amp; Services</topic><topic>Life Sciences &amp; Biomedicine</topic><topic>Medical colleges</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Mucositis</topic><topic>Nursing</topic><topic>Nursing Research</topic><topic>Oncology</topic><topic>Oncology, Experimental</topic><topic>Original Article</topic><topic>Pain Medicine</topic><topic>Palliative care</topic><topic>Radiation therapy</topic><topic>Rehabilitation</topic><topic>Rehabilitation Medicine</topic><topic>Science &amp; Technology</topic><topic>Stomatitis</topic><topic>Taste disorders</topic><topic>World health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Morais-Faria, Karina</creatorcontrib><creatorcontrib>Palmier, Natalia Rangel</creatorcontrib><creatorcontrib>de Lima Correia, Jaqueline</creatorcontrib><creatorcontrib>de Castro Júnior, Gilberto</creatorcontrib><creatorcontrib>Dias, Reinaldo Brito</creatorcontrib><creatorcontrib>da Graça Pinto, Henrique</creatorcontrib><creatorcontrib>Lopes, Marcio Ajudarte</creatorcontrib><creatorcontrib>Ribeiro, Ana Carolina Prado</creatorcontrib><creatorcontrib>Brandão, Thaís Bianca</creatorcontrib><creatorcontrib>Santos-Silva, Alan Roger</creatorcontrib><collection>Web of Science - Science Citation Index Expanded - 2020</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Social Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Sociology Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Social Science Database</collection><collection>Sociology Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Supportive care in cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Morais-Faria, Karina</au><au>Palmier, Natalia Rangel</au><au>de Lima Correia, Jaqueline</au><au>de Castro Júnior, Gilberto</au><au>Dias, Reinaldo Brito</au><au>da Graça Pinto, Henrique</au><au>Lopes, Marcio Ajudarte</au><au>Ribeiro, Ana Carolina Prado</au><au>Brandão, Thaís Bianca</au><au>Santos-Silva, Alan Roger</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Young head and neck cancer patients are at increased risk of developing oral mucositis and trismus</atitle><jtitle>Supportive care in cancer</jtitle><stitle>Support Care Cancer</stitle><stitle>SUPPORT CARE CANCER</stitle><addtitle>Support Care Cancer</addtitle><date>2020-09-01</date><risdate>2020</risdate><volume>28</volume><issue>9</issue><spage>4345</spage><epage>4352</epage><pages>4345-4352</pages><issn>0941-4355</issn><eissn>1433-7339</eissn><abstract>Objectives To evaluate cancer treatment–related toxicities in young head and neck cancer (HNC) patients. Material and methods A total of 44 patients were included in the present retrospective cohort study, which was designed to access oral toxicities of cancer treatment in young (&lt; 45 years of age, Group I, n  = 22) and old (&gt; 58 years of age, Group II, n  = 22) HNC patients with similar tumor stage and treatment protocols. Oral mucositis (OM), xerostomia, dysphagia, dysgeusia, trismus, and radiodermatitis were assessed during days 7th, 21st, and 35th of head and neck radiotherapy (HNRT) according to previously validated scales (World Health Organization criteria and the National Cancer Institute and Common Terminology Criteria for Adverse Events version 4.0). Results Patients from both groups showed high incidence and severity of oral toxicities by the end of the HNRT with OM (81.9% (Group I); 63.6% (Group II)) and xerostomia (72.6% (Group I); 77.2% (Group II)) being the most prevalent toxicities. No differences regarding xerostomia, dysphagia, dysgeusia, and radiodermatitis incidences or severity could be observed between groups. However, higher incidences and severity of OM at 21st and 35th fractions (odds ratio = 2.22 and 5.71, respectively) and trismus at 21st and 35th fractions (odds ratio = 6.17 and 14.5, respectively) were observed throughout the treatment in young patients when compared to older patients ( p  &lt; 0.01 and p  &lt; 0.05, respectively). Conclusion Young HNC patients are more affected by cancer treatment–related OM and trismus despite the similarities in clinical staging and treatment protocols with elderly patients.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>31912359</pmid><doi>10.1007/s00520-019-05241-x</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-2040-6617</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0941-4355
ispartof Supportive care in cancer, 2020-09, Vol.28 (9), p.4345-4352
issn 0941-4355
1433-7339
language eng
recordid cdi_gale_infotracmisc_A630447329
source SpringerNature Journals; Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />
subjects Cancer
Cancer patients
Cancer therapies
Deglutition disorders
Dysphagia
Head & neck cancer
Head and neck cancer
Health Care Sciences & Services
Life Sciences & Biomedicine
Medical colleges
Medicine
Medicine & Public Health
Mucositis
Nursing
Nursing Research
Oncology
Oncology, Experimental
Original Article
Pain Medicine
Palliative care
Radiation therapy
Rehabilitation
Rehabilitation Medicine
Science & Technology
Stomatitis
Taste disorders
World health
title Young head and neck cancer patients are at increased risk of developing oral mucositis and trismus
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T17%3A40%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Young%20head%20and%20neck%20cancer%20patients%20are%20at%20increased%20risk%20of%20developing%20oral%20mucositis%20and%20trismus&rft.jtitle=Supportive%20care%20in%20cancer&rft.au=Morais-Faria,%20Karina&rft.date=2020-09-01&rft.volume=28&rft.issue=9&rft.spage=4345&rft.epage=4352&rft.pages=4345-4352&rft.issn=0941-4355&rft.eissn=1433-7339&rft_id=info:doi/10.1007/s00520-019-05241-x&rft_dat=%3Cgale_pubme%3EA630447329%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2426369648&rft_id=info:pmid/31912359&rft_galeid=A630447329&rfr_iscdi=true